Corporate Eye

Cytokinetics A Unique Company

In my continuing search for interesting websites, I came upon Cytokinetics. The name itself was enough to make me look further. When I looked for what the company does, I found this —

Cytokinetics is a different kind of company. It is increasingly unusual that an emerging growth biotechnology company would be dedicated to the discovery, development and commercialization of therapeutics. Similarly, it is more and more uncommon for a biopharmaceutical company to leverage their expertise in one area, in our case the cytoskeleton and the biology of muscle function, to tackle the pursuit of new treatments for multiple disease areas.

cytoskeleton–System of protein filaments in the cytoplasm of a eucaryotic cell that gives the cell a polarized shape and the capacity for directed movement. Its most abundant components are actin filaments, microtubules, and intermediate filaments.

Hmm, I am starting to understand the genesis of the company’s name but I’m still not clear about what the company does. To its credit, the company offers additional information in their Research Section. There is a video that uses a city as a metaphor to explain cytoskeleton. However, and oddly, there is no audio. 

There are more resources on the Cardiac Muscle Contractility section.

This video has audio and does a decent job explaining technical information. The company provides more technical explanations on its Our Research but more videos such as this one would be useful to potential investors.

Another good feature on the website is the visual display of their product pipeline —

This is good but would be better if they added explanations of what the Phases mean–

PHASE I TRIALS: Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.

PHASE II TRIALS: Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks.

PHASE III TRIALS: Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling.

PHASE IV TRIALS: Post-marketing studies to delineate additional information including the drug’s risks, benefits, and optimal use.


Suggestion: The company is headed in the right direction regarding education on its products. It would do well to provide more videos and perhaps put this and other information in one section.

Finally another good feature is that the company offers a video, with David Cragg, SVP Human Human Resources, that outlines the Corporate Culture. Most corporate websites that display their Culture do so typically in text. Cytokinetics is unusual in providing a video.

Cytokinetics — a company with unique products and an interesting website.

The following two tabs change content below.
Ed Konczal has an MBA from New York University's Stern School of Business (with distinction). He has spent the last 10 years as an executive consultant focusing on human resources, leadership, market research, and business planning. Ed has over 10 years of top-level experience from AT&T in the areas of new ventures and business planning. He is co-author of the book "Simple Stories for Leadership Insight," published by University Press of America.